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Abstract
Introduction Changes in sulfation of cartilage
glycosaminoglycans as mediated by sulfatases can regulate
growth factor signaling. The aim of this study was to analyze
expression patterns of recently identified extracellular sulfatases
Sulf-1 and Sulf-2 in articular cartilage and chondrocytes.
Methods Sulf-1 and Sulf-2 expressions in human articular
cartilage from normal donors and patients with osteoarthritis
(OA) and in normal and aged mouse joints were analyzed by
real-time polymerase chain reaction, immunohistochemistry, and
Western blotting.
Results In normal articular cartilage, Sulf-1 and Sulf-2 mRNAs
and proteins were expressed predominantly in the superficial
zone. OA cartilage showed significantly higher Sulf-1 and Sulf-
2 mRNA expression as compared with normal human articular
cartilage. Sulf protein expression in OA cartilage was prominent
in the cell clusters. Western blotting revealed a profound
increase in Sulf protein levels in human OA cartilage. In normal
mouse joints, Sulf expression was similar to human cartilage,
and with increasing age, there was a marked upregulation of
Sulf.
Conclusion The results show low levels of Sulf expression,
restricted to the superficial zone in normal articular cartilage.
Sulf mRNA and protein levels are increased in aging and OA
cartilage. This increased Sulf expression may change the
sulfation patterns of heparan sulfate proteoglycans and growth
factor activities and thus contribute to abnormal chondrocyte
activation and cartilage degradation in OA.
Introduction
Osteoarthritis (OA) is the most prevalent joint disease and is
characterized by degradation of articular cartilage, subchon-
dral bone remodeling, and joint inflammation [1,2]. Chondro-
cytes in OA cartilage are activated by cytokines and growth
factors [3,4] to a catabolic phenotype that leads to progres-
sive extracellular matrix (ECM) destruction and abnormal
chondrocyte differentiation [4,5]. Cartilage ECM consists of
collagens, glycoproteins, proteoglycans, and glycosaminogly-
cans (GAGs). The major GAGs in cartilage are hyaluronic
acid, chondroitin sulfate, keratan sulfate, dermatan sulfate, and
heparan sulfate. GAGs were previously shown to be important
determinants of cartilage biomechanical properties but also
have recently been shown to bind and regulate the activity of
several cytokines and growth factors. In particular, the sulfa-
tion patterns of GAGs are critical in determining the binding
capacity and specificity for cytokines and growth factors [6-9].
Heparan sulfate proteoglycans (HSPGs) also act as co-recep-
tors for heparin-binding growth factors and cytokines [10].
The sulfation of heparan sulfate residues is required for inter-
actions with heparin-binding factors that are also know to be
important regulators of chondrocytes, including Wnt, fibrob-
last growth factor (FGF), vascular endothelial growth factor
(VEGF), and bone morphogenetic proteins (BMPs) [11-14].
Sulfotransferases and sulfatases establish GAG sulfation in
the endoplasmatic reticulum and Golgi network prior to
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secretion [15]. Classic sulfatases are intracellular enzymes
that cleave sulfate esters from substrates that range from small
cytosolic steroids, such as estrogen sulfate, to complex cell
surface carbohydrates, such as the GAGs [15]. A novel class
of extracellular heparan sulfate 6-O endosulfatase (Sulf) has
recently been identified and in mammalians includes two iso-
forms, Sulf-1 and Sulf-2 [16-18]. These enzymes exist in a cell
surface-associated and soluble form and hydrolyze the 6-O
sulfate of HSPGs [17,19]. Most of the current information on
Sulf-1 and Sulf-2 is related to cancer and development [20-
23]. Specifically, 6-O sulfation of heparan sulfate is required
for receptor dimerization and FGF signaling while 6-O desul-
fation is associated with reduced FGF2 signaling [24]. Sulf-1
also regulates Wnt signaling through desulfation of cell sur-
face HSPGs [16].
OA is associated with changes in GAG expression levels and
sulfation patterns [6,8,9], but mechanisms and consequences
remain to be analyzed. This study addresses the hypothesis
that the novel extracellular sulfatases may be involved in regu-
lating the growth factor signaling balance in articular cartilage.
The results show that Sulf-1 and Sulf-2 are (a) expressed in
human articular cartilage, and (b) are preferentially expressed
in the superficial zone and that (c) their expression is altered in
osteoarthritic and aging cartilage.
Materials and methods
Cartilage procurement and processing
All tissue samples were graded according to a modified
Mankin scale [25], with a score of less than 3 points being nor-
mal and a score of greater than 5 representing OA [26]. Nor-
mal articular cartilage was harvested from femoral condyles
and tibial plateaus of human tissue donors under approval of
the Scripps Human Subjects Committee. Osteoarthritic carti-
lage was obtained from patients undergoing knee replace-
ment surgery. The thickness of these cartilages ranged from
1.5 to 2.8 mm. Once cartilage surfaces were rinsed with
saline, scalpels were used to cut parallel sections 5 mm apart,
vertically from the cartilage surface onto the subchondral
bone. These cartilage strips were then resected from the
bone. Human chondrocytes were isolated and cultured as
described previously [27]. The cartilage tissue was incubated
with trypsin at 37°C for 10 minutes. After the trypsin solution
was removed, the tissue slices were treated for 12 to 16 hours
with type IV clostridial collagenase in Dulbecco's modified
Eagle's medium (DMEM) with 5% fetal calf serum. After initial
isolation, the cells were kept in high-density cultures in DMEM
(high glucose) supplemented with 10% CS, L-glutamine, and
antibiotics and allowed to attach to the surface of the culture
flasks. After the cells had grown to confluence, they were split
once (passage 1) and grown to confluence again for use in the
experiments.
RNA isolation from cartilage and cultured chondrocytes
RNA was isolated from fresh frozen cartilage by homogenizing
the tissue in a freezer mill (Spex CertiPrep, Inc., Metuchen, NJ,
USA) and extracting the homogenate in Trizol (Life Technolo-
gies, Inc., now part of Invitrogen Corporation, Carlsbad, CA,
USA). The samples were extracted with chloroform and centri-
fuged at 15,000 g for 20 minutes, and the aqueous phase was
collected. An equal volume of 70% ethanol was added, mixed,
and applied to RNeasy columns (Qiagen Inc., Valencia, CA,
USA). RNA concentrations were determined using RiboGreen
reagent (Molecular Probes Inc., now part of Invitrogen Corpo-
ration). Total RNA was isolated from chondrocyte cultures
plated at confluence at 3 × 106 cells per 100-mm plate using
the RNeasy kit (Qiagen Inc.) with on-column DNA digestion.
Complementary DNA was produced using the SuperScript III
First-Strand kit (Invitrogen Corporation) with random
hexamers.
Quantitative polymerase chain reaction for Sulf-1 and 
Sulf-2
Sulf-1 and Sulf-2 primers and conditions for reverse transcrip-
tion-polymerase chain reaction (RT-PCR) were based on the
protocol of Morimoto-Tomita and colleagues [17]. Real-time
RT-PCR with SYBR green detection was performed using an
iCycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA) as fol-
lows: 2 minutes at 50°C and then 10 minutes at 95°C for initial
denaturation, followed by 40 cycles at 95°C (15 seconds),
60°C (1 minute), followed by the measurement of fluores-
cence at the end of each cycle. Each run included a melting
curve to determine the correct response of the primers [28].
The following primers were used: Sulf-1: forward 5'-AGAC-
CTAAGAAT CTTGATGTTGGAA-3', reverse 5'-CCATC-
CCATAACTGTCCTCTG-3'(74 base pairs [bp], NM15170),
Sulf-2: forward 5'-TGAGGGAAGTCCGAGGTCAC-3',
reverse 5'-CTTGCGGAGTTTCTTCTTGC-3' (194 bp,
NM018837, NM198596), glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH): forward 5'-ACCCACTCCTCCAC-
CTTTGA-3', reverse 5'-ATGAGGTCCACCACCCTGTT-3'.
Primers were selected in consideration of the low homology
between the sequences of Sulf-1 and Sulf-2. Furthermore,
human Sulf-2 primers were designed to detect both Sulf-2
splice variants, NM 018837 and NM 198596. The specificity
of detection of Sulf-1 and Sulf-2 was confirmed by sequencing
the PCR products after isolation with the QIAquick gel extrac-
tion kit (Qiagen Inc.). Changes in Sulf gene expression were
calculated relative to GAPDH.
Histology and immunohistochemistry
Cartilage tissues were fixed with 4% paraformaldehyde and
stained with safranin O. Sulf antibodies were purchased from
Abcam Inc. (Cambridge, MA, USA). Paraffin-fixed samples
were first deparaffinized in xylene substitute Pro-Par Clearant
(Anatech Ltd., Battle Creek, MI, USA), ethanol then water for
rehydration. After washing with PBS, sections were blockedAvailable online http://arthritis-research.com/content/10/3/R61
Page 3 of 8
(page number not for citation purposes)
with 0.1% Tween20 with 3% normal goat serum for 30 min-
utes at room temperature. Sulf-1 and Sulf-2 antibodies (2 μg/
mL) and normal mouse IgG (1 μg/mL) as negative control
were applied and incubated overnight at 4°C. After washing
with PBS, sections were incubated with biotinylated goat anti-
mouse secondary antibody for 30 minutes (1:200; Vector Lab-
oratories Inc., Burlingame, CA, USA) and then incubated with
Vectastain ABC-AP kit (AK-5000; Vector Laboratories Inc.) for
30 minutes at room temperature. Finally, sections were
stained with an alkaline phosphatase substrate kit (Vector Lab-
oratories Inc.).
Quantification and localization of signals throughout 
cartilage
Sulf-1 and Sulf-2 localization throughout each cartilage zone
was assessed systematically by counting positive and nega-
tive cells in a 50 × 50 μm grid (using a ×40 field objective)
starting from the cartilage surface to the deep zone. This was
repeated a minimum of five times for each section. The identi-
fication of each zone was based on previously reported char-
acteristics that comprise cell shape, morphology, orientation,
and pericellular matrix (PM) deposition [29]. Thus, superficial
zone (SZ) cells were characterized by their elongated shape,
their parallel orientation relative to the surface, and lack of
extensive PM. These cells predominate within the first 50 μm.
The middle zone (MZ) was distinguishable by rounded cells
that did not exhibit an organized orientation relative to the sur-
face, that have ECM rich in proteoglycans, and that show the
presence of PM. Conversely, deep zone (DZ) cells were rec-
ognized with an extensive PM deposition and organized in col-
umns of chondron groups of three or more cells. The depth of
each zone was recorded for each section for comparative
analysis on the frequency of positive signal in each zone. The
frequency of positive cells was expressed as a percentage rel-
ative to the total number of cells counted in each zone.
Western blotting
Cartilage was cut into 1-mm-thin slices, and 200 to 1,000 mg
of frozen cartilage was pulverized in a liquid nitrogen-cooled
freezer mill for two cycles of 1.5 minutes at the rate of maxi-
mum impact frequency. Dry weight of normal and OA cartilage
was measured and the same amount of protein was resus-
pended in SDS gel loading buffer (50 mM Tris pH 6.8, 10%
glycerol, 4% sodium dodecyl sulfate, 10% 2-mercaptoethanol,
and 0.001% bromophenol blue) and mixed for 2 hours at room
temperature. Centrifugation at 14,000 rpm was performed for
30 minutes and then supernatants were harvested and heated
at 80°C for 10 minutes. The concentrated samples were then
adjusted for equal volumes before resolution on 12% Tris-Gly-
cine gels (Invitrogen Corporation). Protein was transferred to
nitrocellulose membranes (Invitrogen Corporation), blocked
with 5% dry milk in Tris-buffered saline–Tween (TBST), and
blotted with mouse polyclonal antibody specific for Sulf-1 or
Sulf-2 (Abcam Inc.) for 1 hour. The membranes were then
incubated with horseradish peroxidase-conjugated anti-
mouse IgG (Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA) for 1 hour. Afterwards, the membranes were washed
three times with TBST and developed using the enhanced
chemiluminescent substrate from Pierce (Rockford, IL, USA).
Analysis of murine joints
All animal experiments were performed according to protocols
approved by the Institutional Animal Care and Use Committee
at The Scripps Research Institute (La Jolla, CA, USA). Sulf-1
and Sulf-2 expression was analyzed by immunohistochemistry
in temporomandibular (TM) joints and knee joints of 1-, 6-, 9-,
and 12-month-old C57BL/6J mice. Each mouse joint was cut
in half along the mid-sagittal plane and fixed in 10% zinc-buff-
ered formalin (Z-Fix; Anatech Ltd.) for 2 to 3 days and then
decalcified in Shandon TBD-2 decalcifier (Fisher Scientific
Pittsburgh, PA, USA) for 2 to 3 weeks. Three-millimeter serial
sections (from posterior to anterior) were cut and immunos-
tained for Sulf-1 and Sulf-2 as described above.
Statistical analysis
Statistically significant differences between two groups were
determined with t tests. The results are reported as mean ±
standard deviation. P values of less than 0.05 were consid-
ered significant.
Results
Sulf gene expression in articular cartilage
Sulf-1 and Sulf-2 mRNA expression in eight OA donors (49 to
68 years old; Mankin score: 7 to 10 points) was significantly
higher than in eight young donors (19 to 37 years old; Mankin
score: 0 to 2 points) as determined by real-time PCR (Figure
1).
Localization of Sulf-1 and Sulf-2 proteins in human 
articular cartilage
Young and old normal samples as seen on safranin O staining
(Figure 2a, d, g) had only a few Sulf-positive cells in the super-
Figure 1
Sulf mRNA expression in normal and osteoarthritis (OA) cartilage Sulf mRNA expression in normal and osteoarthritis (OA) cartilage. Sulf-
1 and Sulf-2 mRNA expression in articular cartilage were determined 
by quantitative polymerase chain reaction in eight normal (mean age: 
20.3 years, range: 19 to 37 years; Mankin score: 0 to 2 points) and 
eight OA (mean age: 57 years, range: 49 to 68 years; Mankin score: 7 
to 10 points) donors. Both Sulf-1 and Sulf-2 expression were signifi-
cantly higher in the OA group (Sulf-1: P = 0.001, Sulf-2: P = 0.019).Arthritis Research & Therapy    Vol 10 No 3    Otsuki et al.
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ficial zone (Figure 2b, c, e, f, h, i) and no positive cells in the
middle and deep zones. In general, the expression of Sulf-2
appeared more intense than Sulf-1 in normal cartilage. In OA
cartilage, many positive cells were detected, especially in
chondrocyte clusters (Figure 3g, h, k, l). The representative
example of 65-year-old cartilage had both normal areas
(Mankin score: 2) (Figure 3a, b) and OA areas with fibrillations
and cluster formation (Mankin score: 8) (Figure 3c, d). The nor-
mal appearing areas from OA joints had 18.5% Sulf-1-positive
and 31.9% Sulf-2-positive cells in the superficial zone (Figure
3e, f, i, j), which was greater than in normal cartilage (Figure 2).
On the other hand, OA areas had 75.3% Sulf-1-positive and
73.2% Sulf-2-positive cells (Figure 3g, h, k, l).
Figure 4 shows quantitative analysis of the zonal distribution of
Sulf-1- and Sulf-2-expressing cells in eight normal (17 to 37
years old) and eight OA (43 to 82 years old) donors. In OA,
the superficial zone was already eroded. The middle zone in
OA cartilage had significantly more positive cells than normal
(*P < 0.01). Moreover, the number of Sulf-2-positive cells in
the superficial and middle zones was greater than Sulf-1-
expressing cells (P = 0.02).
Western blotting was performed to visualize Sulf proteins and
determine differences in the expression between normal and
OA. In total protein extracts from normal cartilage, Sulf-1 and
Sulf-2 were not detectable. In contrast, high levels of Sulf-1
and Sulf-2 protein were detected in OA cartilage (Figure 5).
The major Sulf-1 and Sulf-2 protein bands migrated at approx-
imately 72 kDa, which is the molecular mass of the secreted
proteins [17,30,31].
Sulf-1 and Sulf-2 expression in murine joints
TM joints from normal C57BL/6J mice (n = 6) were analyzed
with safranin O staining (Figure 6a–c) and immunohistochem-
istry for Sulf-1 and Sulf-2 (Figure 6d–i). Histology showed
thinning and reduced cell density in articular cartilage with
increasing age (Figure 6c). In 6-month-old mice, only a few
cells were positive for Sulf-1 but Sulf-2-positive cells were
present throughout the cartilage. There was a marked increase
in Sulf-2 expression at 9 months and in Sulf-1 expression at 12
months. In murine knee joints (n = 8), there was high Sulf
expression at 1 month of age, followed by a decrease with joint
maturation. Increased expression of Sulf-1 and Sulf-2 was
seen in the articular cartilage of murine knee joints by 12
months of age, when early OA-like changes become apparent
(Figure 7).
Discussion
Chondrocytes in osteoarthritic cartilage are activated by
cytokines, growth factors, and mechanical stress to produce
matrix-degrading enzymes and pro-inflammatory cytokines
with an overall shift from anabolic to catabolic responses
[32,33]. Besides control of gene expression, protein synthe-
sis, and secretion, the biological activity of cytokines and
growth factors is regulated by binding to ECM proteins such
as GAGs [34,35]. The sulfation pattern of HSPGs has
recently been shown to be critical for determining the specifi-
city and affinity of binding to growth factors and morphogens
[36]. The sulfation patterns of HSPGs are determined during
intracellular biosynthesis and can be further modified on cell
surface-associated and extracellular HSPGs by a novel class
of extracellular sulfatases which includes two enzymes, Sulf-1
and Sulf-2. Previously, Sulf-1 and Sulf-2 mRNAs were shown
to be expressed at high levels in regions of developing carti-
lage and bone [37]. The present study reports on the expres-
sion of Sulf in mature cartilage and changes with aging and
OA.
In normal articular cartilage, Sulf-1 and Sulf-2-positive cells
were predominantly localized in the superficial zone and Sulf-
2 was more highly expressed than Sulf-1. This observation
adds further to the zone-specific differences of chondrocyte
subsets, in particular of the superficial zone cells [38-40].
OA cartilage showed higher expression of Sulf-1 and Sulf-2 as
compared with normal tissue in all experimental approaches
used in the present study, including quantitative PCR on carti-
lage and cultured chondrocytes, immunohistochemistry, and
Western blotting. Aging and OA are closely linked. To address
Figure 2
Localization of Sulf-1 and Sulf-2 in normal cartilage Localization of Sulf-1 and Sulf-2 in normal cartilage. Representative 
sections of 26-year-old (a, d) and 74-year-old (g) normal cartilage 
(Mankin scores: 0 and 2) as seen on safranin O staining are shown (n = 
8; 19 to 37 years old). Sulf-positive cells (brown staining) are present in 
the superficial zone and the top of the middle zone, and Sulf-2 expres-
sion is greater than Sulf-1 (b, c, e, f, h, i) in both young and old carti-
lage. Magnifications: ×10 (a-c) and ×40 (d-i).Available online http://arthritis-research.com/content/10/3/R61
Page 5 of 8
(page number not for citation purposes)
the influence of these variables on Sulf expression, we ana-
lyzed normal-appearing and fibrillated cartilages in the same
joints from patients with OA. In the OA joints, Sulf expression
was higher in the fibrillated areas. Even in areas that had
almost normal surface layers and safranin O staining patterns,
Sulf expression was higher than in normal cartilage from young
healthy donors. The TM joint is an important growth and artic-
ulation center in the craniofacial complex, and with aging, it
develops spontaneous degenerative OA lesions [41]. TM
joints showed strongly increased Sulf expression between 6
and 12 months of age, when cartilage thickness and cellularity
were reduced, but fibrillations had not yet developed. Sulf
expression was also determined in murine knee joints.
Interestingly, Sulf expression was high at 1 month of age and
Figure 3
Localization of Sulf-1 and Sulf-2 in normal-appearing and fibrillated cartilage from the same osteoarthritis (OA) donor Localization of Sulf-1 and Sulf-2 in normal-appearing and fibrillated cartilage from the same osteoarthritis (OA) donor. Sulf localization was deter-
mined with 16 donors (19 to 82 years old). Cartilage from a representative 65-year-old donor had both normal areas (Mankin score: 2) and OA areas 
(Mankin score: 8). Sulf-positive cells were more frequent in OA areas than in normal-appearing cartilage. Magnifications: ×10 (a, c, e, g, i, k) and 
×100 (b, d, f, h, j, l).
Figure 4
Sulf-1 and Sulf-2 expression in specific zones of normal and osteoarthritis (OA) cartilage Sulf-1 and Sulf-2 expression in specific zones of normal and osteoarthritis (OA) cartilage. The number of Sulf-1- or Sulf-2-positive cells was counted 
in the superficial, middle, and deep zones of sections from normal (n = 8) and OA (n = 8) cartilage that were stained with specific antibodies. In nor-
mal cartilage, the percentage of Sulf-2-positive cells was highest in the superficial zone. The superficial zone in OA cartilage was eroded. The OA 
middle zone had significantly more Sulf-1-positive cells than the other zones (*P < 0.01). Sulf-2 expression in normal cartilage was significantly 
higher than Sulf-1 (P = 0.02).Arthritis Research & Therapy    Vol 10 No 3    Otsuki et al.
Page 6 of 8
(page number not for citation purposes)
decreased with joint maturation, suggesting a role in this proc-
ess. By 12 months of age, Sulf expression increased again
with the simultaneous development of OA-like changes. Taken
together, these findings from human and murine joints indicate
that Sulfs are upregulated with age and at early stages of the
matrix degradation process.
The present observations of increased Sulf expression sug-
gest a role in OA pathogenesis. Altered GAG sulfation pat-
terns on chondroitin sulfate and dermatan sulfate have been
reported in aging and OA [9,42], but changes in heparan sul-
fation patterns under these conditions have not yet been ana-
lyzed. The HSPGs are potential targets of Sulf [19], and their
expression in articular cartilage and changes in OA have been
demonstrated in several previous publications on syndecan
[43-49], perlecan [50-54], and glypican [44,54]. In particular,
syndecan-1, syndecan-3 [45,46], and perlecan [50] are over-
expressed in severe OA. Furthermore, some of these studies
have shown that HSPGs are overexpressed, specifically in cell
clusters in OA cartilage. In this study, we also showed Sulf-1
and Sulf-2 overexpression in OA cartilage, particularly in clus-
ters. Collectively, this information documents the presence of
the HSPGs that are the major known sulfatase substrates in
articular cartilage. In addition, there appears to be similar
expression of the enzymes and substrates in OA-affected car-
tilage. Changes in sulfation of heparan sulfate are important in
cell behavior and organogenesis [55] and affect several
growth factor signaling pathways. 6-O sulfated heparan sul-
fates are required for FGF receptor dimerization. Sulf-1 desul-
fates cell surface heparan sulfate and inhibits FGF signaling
[24,56]. Im and colleagues [57] showed that FGF2 induced
matrix metalloproteinase-13 in articular chondrocyte and con-
tributes to OA progression. FGF2 may regulate Sulf
expression and maintain the anabolic and catabolic balance in
cartilage.
Sulf-1 also mediates 6-O desulfation of the heparan sulfate-
Wnt complex so that it interacts with Frizzled receptor, initiat-
ing Wnt target gene expression [19]. Wnt signaling is
important in cartilage. Wnt and β-catenin activation are
associated with inhibition of type II collagen expression [58]
with GAG loss [8] and abnormal chondrocyte differentiation in
OA [59]. Thus, Wnt signaling, activated by Sulf, may acceler-
ate the progression of OA. Sulf-1 regulates BMP signaling,
which is important in cartilage homeostasis. The BMP antago-
nist Noggin is a heparin-binding protein that is associated with
the cell surface through HSPGs, where it inhibits BMP signal-
ing. Sulf-1 desulfates heparan sulfate, releases Noggin, and
thus restoring BMP signaling [11].
Conclusion
This study is the first to show increased Sulf expression in OA
cartilage. Sulf-1 and Sulf-2 are highly expressed in OA carti-
lage, especially in clusters and even in normal-appearing carti-
lage in OA joints. The ability of Sulfs to regulate growth factor
pathways (such as FGF, Wnt, or BMP) that are important in
cartilage suggests that their overexpression in OA contributes
to the abnormal chondrocyte activation and ECM degradation.
Inhibition of Sulfs may represent a new approach to correct
these pathogenetic processes.
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